Matulonis UA - Search Results

1

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.

Mirza MR, Benigno B, Dørum A, Mahner S, Bessette P, Barceló IB, Berton-Rigaud D, Ledermann JA, Rimel BJ, Herrstedt J, Lau S, du Bois A, Herráez AC, Kalbacher E, Buscema J, Lorusso D, Vergote I, Levy T, Wang P, de Jong FA, Gupta D, Matulonis UA. Mirza MR, et al. Among authors: matulonis ua. Gynecol Oncol. 2020 Nov;159(2):442-448. doi: 10.1016/j.ygyno.2020.09.006. Epub 2020 Sep 25. Gynecol Oncol. 2020. PMID: 32981695 Clinical Trial.

2

Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.

Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, Niloff J, Cannistra SA. Tung N, et al. Gynecol Oncol. 2000 May;77(2):271-7. doi: 10.1006/gyno.2000.5778. Gynecol Oncol. 2000. PMID: 10785477 Clinical Trial.

3

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A, Seiden MV. Campos SM, et al. Among authors: matulonis ua. Gynecol Oncol. 2001 May;81(2):206-12. doi: 10.1006/gyno.2000.5980. Gynecol Oncol. 2001. PMID: 11330951

4

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy.

Seiden MV, Swenerton KD, Matulonis U, Campos S, Rose P, Batist G, Ette E, Garg V, Fuller A, Harding MW, Charpentier D. Seiden MV, et al. Gynecol Oncol. 2002 Sep;86(3):302-10. doi: 10.1006/gyno.2002.6762. Gynecol Oncol. 2002. PMID: 12217752 Clinical Trial.

5

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.

Campos SM, Matulonis UA, Penson RT, Lee H, Berkowitz RS, Duska LR, Fuller AF Jr, Wilson KS, Puchalski TA, Supko JG, Seiden MV. Campos SM, et al. Among authors: matulonis ua. Gynecol Oncol. 2003 Sep;90(3):610-8. doi: 10.1016/s0090-8258(03)00373-1. Gynecol Oncol. 2003. PMID: 13678734 Clinical Trial.

6

A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.

Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S, Roche M, Colella T, Lee H, Seiden MV; Gynecologic Oncology Research Program at Dana Farber/Partners Cancer Care; Dana Farber-Harvard Cancer Care. Matulonis U, et al. Gynecol Oncol. 2003 Nov;91(2):293-8. doi: 10.1016/s0090-8258(03)00496-7. Gynecol Oncol. 2003. PMID: 14599858 Clinical Trial.

7

Phase II trial of anastrozole in women with asymptomatic müllerian cancer.

del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.

8

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer.

Seiden MV, Muggia F, Astrow A, Matulonis U, Campos S, Roche M, Sivret J, Rusk J, Barrett E. Seiden MV, et al. Gynecol Oncol. 2004 Apr;93(1):229-32. doi: 10.1016/j.ygyno.2003.12.037. Gynecol Oncol. 2004. PMID: 15047241 Clinical Trial.

9

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.

Penson RT, Seiden MV, Goodman A, Fuller AF Jr, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare. Penson RT, et al. Among authors: matulonis ua. Gynecol Oncol. 2004 Jun;93(3):702-7. doi: 10.1016/j.ygyno.2004.02.028. Gynecol Oncol. 2004. PMID: 15196868 Clinical Trial.

10

Attitudes to chemotherapy in patients with ovarian cancer.

Penson RT, Dignan F, Seiden MV, Lee H, Gallagher CJ, Matulonis UA, Olson K, Gibbens I, Gore ME. Penson RT, et al. Among authors: matulonis ua. Gynecol Oncol. 2004 Aug;94(2):427-35. doi: 10.1016/j.ygyno.2004.05.034. Gynecol Oncol. 2004. PMID: 15297184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters